

Can't find Amoxicillin/Clarithromycin/Lansoprazole (Prevpac)? Learn about effective alternative H. pylori treatments your doctor can prescribe instead.
You've been diagnosed with a Helicobacter pylori (H. pylori) infection, and your doctor prescribed Amoxicillin/Clarithromycin/Lansoprazole — the classic triple therapy also known as Prevpac. But your pharmacy doesn't have it in stock, your insurance won't cover it, or the cost is simply too high.
Don't panic. While it's important to treat H. pylori promptly, this isn't the only effective treatment available. There are several proven alternative regimens that your doctor can prescribe. In this article, we'll explain what Amoxicillin/Clarithromycin/Lansoprazole does, how it works, and walk you through four real alternatives that are backed by clinical evidence.
Amoxicillin/Clarithromycin/Lansoprazole is a combination of three medications used together to eliminate H. pylori bacteria from the stomach. H. pylori is the leading cause of peptic ulcers and can also lead to chronic gastritis and, in rare cases, stomach cancer if left untreated.
The combination includes:
This regimen is taken twice daily for 10 to 14 days. It's often called "triple therapy" because it combines an acid-suppressing drug with two antibiotics.
H. pylori is a stubborn bacterium that thrives in the acidic environment of the stomach. The treatment strategy works on two levels:
When taken correctly for the full course, this triple therapy eradicates H. pylori in approximately 70-85% of patients. However, rising rates of Clarithromycin resistance in some regions have led medical guidelines to recommend alternatives in areas where resistance exceeds 15%.
This is the most widely recommended alternative to Clarithromycin-based triple therapy and is now considered a first-line treatment by the American College of Gastroenterology (ACG).
What's in it:
How it's taken: The PPI is taken twice daily, while Bismuth, Metronidazole, and Tetracycline are taken four times daily for 14 days.
Why it's a good alternative: Bismuth Quadruple Therapy is effective even in areas with high Clarithromycin resistance. It uses completely different antibiotics, so if your H. pylori is resistant to Clarithromycin, this regimen can still work. Eradication rates are 85-90% when taken for a full 14 days.
Downsides: The pill burden is higher (you'll take more pills per day), and side effects like nausea, dark stools, and metallic taste are common. The complexity of the dosing schedule can make adherence challenging.
Cost: Generally $30–$80 with coupons for the generic components, making it significantly cheaper than the Prevpac kit.
This is the newest FDA-approved option for H. pylori and represents a significant advance in treatment.
What's in it:
How it's taken: Both medications are taken twice daily for 14 days. That's just four pills per day — simpler than most other H. pylori regimens.
Why it's a good alternative: Vonoprazan provides faster, stronger, and more consistent acid suppression than PPIs like Lansoprazole. Clinical trials showed eradication rates of 78-84% with just two drugs. The simpler regimen also means better patient adherence.
Downsides: Voquezna is a newer, brand-name medication and is more expensive than generic options. It may require prior authorization from your insurance.
Cost: Around $400–$600 without insurance, though manufacturer coupons may be available.
Talicia is an FDA-approved combination capsule containing Omeprazole, Amoxicillin, and Rifabutin — all in one pill.
What's in it:
How it's taken: Four capsules taken three times daily for 14 days (12 pills per day total).
Why it's a good alternative: Rifabutin resistance among H. pylori strains is extremely rare, making Talicia a strong choice when Clarithromycin or Metronidazole resistance is a concern. Clinical trials showed eradication rates of approximately 84%.
Downsides: The high pill count (12 per day) can be challenging. Rifabutin can also cause side effects including nausea and, rarely, bone marrow suppression. Talicia is a brand-name drug with no generic equivalent yet.
Cost: Approximately $500–$800 without insurance. Patient assistance programs may be available through the manufacturer.
This regimen is typically used as a second-line or salvage therapy after a first treatment attempt has failed.
What's in it:
How it's taken: All three medications twice daily for 14 days.
Why it's a good alternative: Levofloxacin is a fluoroquinolone antibiotic that works differently from both Clarithromycin and Metronidazole. It's typically recommended when first-line treatments fail and can achieve eradication rates of 70-80%.
Downsides: The FDA has issued warnings about serious side effects associated with fluoroquinolones, including tendon damage, nerve damage, and mental health effects. Because of these risks, it's generally reserved for cases where other options have failed. Levofloxacin resistance is also increasing in some regions.
Cost: Approximately $20–$60 for generic components with coupons.
The best alternative depends on your specific situation. Here are some factors to discuss with your doctor:
Not being able to fill your prescription is frustrating, but it doesn't mean you can't get treated. Talk to your doctor about these alternatives, and don't delay treatment — untreated H. pylori can lead to worsening ulcers and more serious complications.
If you'd like to try finding Amoxicillin/Clarithromycin/Lansoprazole before switching, use Medfinder to check pharmacy availability near you. You can also read our guide on how to find it in stock or learn more about how the medication works.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.